Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Chronic and High Frequency Episodic Migraine
NCT01839149Phase 2Completed
- Sponsor
- Trigemina, Inc.
- Start
- May 2013
- Primary completion
- Oct 2015
- Countries
- 3
01
Overview
A Phase 2 trial of oxytocin nasal spray in chronic migraine, episodic migraine, sponsored by Trigemina, Inc.. Started May 2013; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
chronic migraineepisodic migraine
Beyond the preview
Go deeper on NCT01839149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839149.